Biotechnology startup Mestastop Solutions raised Rs 1.3 crore in a seed funding round, led by CIIE.CO. The round also saw participation from IKP Knowledge Park and Angels. Mestastop will use the funding to scale its AI-based platform METSCAN, which characterises cancer cells using patient data samples and their assay panels to understand the cell behaviour. It will further be utilised for running PoC animal model studies to validate proof of concept for cancer drug discovery and repurposing.
Founded in 2018, the Bengaluru-based company has a cross-functional team, trained in discovery, diagnostics and AI, supported by the state-of-the-art infrastructure. Dr Arnab Roy